| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB11
|
ATP-binding cassette, sub-family B (MDR/TAP), member 11
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABI1
|
abl-interactor 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACKR1
|
atypical chemokine receptor 1 (Duffy blood group)
|
|
ACTN3
|
actinin, alpha 3 (gene/pseudogene)
|
|
ACTN4
|
actinin, alpha 4
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ADA
|
adenosine deaminase
|
|
AFP
|
alpha-fetoprotein
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AKAP3
|
A kinase (PRKA) anchor protein 3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALB
|
albumin
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
|
AMPD1
|
adenosine monophosphate deaminase 1
|
|
API5
|
apoptosis inhibitor 5
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
ARTN
|
artemin
|
|
ASNS
|
asparagine synthetase (glutamine-hydrolyzing)
|
|
ASS1
|
argininosuccinate synthase 1
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
ATAD2
|
ATPase family, AAA domain containing 2
|
|
ATOH1
|
atonal homolog 1 (Drosophila)
|
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding
|
|
BAALC
|
brain and acute leukemia, cytoplasmic
|
|
BAG1
|
BCL2-associated athanogene
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BGN
|
biglycan
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
C11ORF30
|
chromosome 11 open reading frame 30
|
|
C4B
|
complement component 4B (Chido blood group)
|
|
CA9
|
carbonic anhydrase IX
|
|
CAPRIN1
|
cell cycle associated protein 1
|
|
CARD8
|
caspase recruitment domain family, member 8
|
|
CARTPT
|
CART prepropeptide
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CCNG2
|
cyclin G2
|
|
CCR10
|
chemokine (C-C motif) receptor 10
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
CD163
|
CD163 molecule
|
|
CD226
|
CD226 molecule
|
|
CD24
|
CD24 molecule
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD82
|
CD82 molecule
|
|
CD8A
|
CD8a molecule
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDR2
|
cerebellar degeneration-related protein 2, 62kDa
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CFH
|
complement factor H
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFP
|
complement factor properdin
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CHAF1B
|
chromatin assembly factor 1, subunit B (p60)
|
|
CHEK2
|
checkpoint kinase 2
|
|
COMT
|
catechol-O-methyltransferase
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CRLF2
|
cytokine receptor-like factor 2
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTGF
|
connective tissue growth factor
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTTN
|
cortactin
|
|
CUL1
|
cullin 1
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
DAO
|
D-amino-acid oxidase
|
|
DCDC2
|
doublecortin domain containing 2
|
|
DCUN1D1
|
DCN1, defective in cullin neddylation 1, domain containing 1
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DRD2
|
dopamine receptor D2
|
|
DRD3
|
dopamine receptor D3
|
|
DSG1
|
desmoglein 1
|
|
DTNBP1
|
dystrobrevin binding protein 1
|
|
DUSP4
|
dual specificity phosphatase 4
|
|
E2F4
|
E2F transcription factor 4, p107/p130-binding
|
|
E2F5
|
E2F transcription factor 5, p130-binding
|
|
EDN1
|
endothelin 1
|
|
EFNA1
|
ephrin-A1
|
|
EFNA2
|
ephrin-A2
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN2
|
egl-9 family hypoxia-inducible factor 2
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ENG
|
endoglin
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPHX2
|
epoxide hydrolase 2, cytoplasmic
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
EVI5
|
ecotropic viral integration site 5
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
F11
|
coagulation factor XI
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FAP
|
fibroblast activation protein, alpha
|
|
FAS
|
Fas cell surface death receptor
|
|
FGB
|
fibrinogen beta chain
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FHIT
|
fragile histidine triad
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOLR1
|
folate receptor 1 (adult)
|
|
FOXC2
|
forkhead box C2
|
|
FOXP1
|
forkhead box P1
|
|
FOXP3
|
forkhead box P3
|
|
FSCN1
|
fascin actin-bundling protein 1
|
|
FSCN2
|
fascin actin-bundling protein 2, retinal
|
|
G6PC2
|
glucose-6-phosphatase, catalytic, 2
|
|
GATA2
|
GATA binding protein 2
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GNAS
|
GNAS complex locus
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HDAC1
|
histone deacetylase 1
|
|
HDGF
|
hepatoma-derived growth factor
|
|
HFE
|
hemochromatosis
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HLTF
|
helicase-like transcription factor
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HOXB7
|
homeobox B7
|
|
HP
|
haptoglobin
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IFN1@
|
interferon, type 1, cluster
|
|
IFNG
|
interferon, gamma
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IL10
|
interleukin 10
|
|
IL13
|
interleukin 13
|
|
IL17F
|
interleukin 17F
|
|
IL18
|
interleukin 18
|
|
IL1B
|
interleukin 1, beta
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IRF4
|
interferon regulatory factor 4
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA9
|
integrin, alpha 9
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
JAG1
|
jagged 1
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KDR
|
kinase insert domain receptor
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KIFC1
|
kinesin family member C1
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT17
|
keratin 17, type I
|
|
KRT19
|
keratin 19, type I
|
|
KRT5
|
keratin 5, type II
|
|
KRT75
|
keratin 75, type II
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LZTS1
|
leucine zipper, putative tumor suppressor 1
|
|
MACC1
|
metastasis associated in colon cancer 1
|
|
MAP1LC3B
|
microtubule-associated protein 1 light chain 3 beta
|
|
MAPT
|
microtubule-associated protein tau
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MEG3
|
maternally expressed 3 (non-protein coding)
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR101-1
|
microRNA 101-1
|
|
MIR1246
|
microRNA 1246
|
|
MIR125A
|
microRNA 125a
|
|
MIR137
|
microRNA 137
|
|
MIR17
|
microRNA 17
|
|
MIR200B
|
microRNA 200b
|
|
MIR205
|
microRNA 205
|
|
MIR20A
|
microRNA 20a
|
|
MIR214
|
microRNA 214
|
|
MIR215
|
microRNA 215
|
|
MIR224
|
microRNA 224
|
|
MIR27A
|
microRNA 27a
|
|
MIR34A
|
microRNA 34a
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MN1
|
meningioma (disrupted in balanced translocation) 1
|
|
MPO
|
myeloperoxidase
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MVP
|
major vault protein
|
|
MX1
|
MX dynamin-like GTPase 1
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYBPC1
|
myosin binding protein C, slow type
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYH7
|
myosin, heavy chain 7, cardiac muscle, beta
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NEFH
|
neurofilament, heavy polypeptide
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFIB
|
nuclear factor I/B
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NGFR
|
nerve growth factor receptor
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOV
|
nephroblastoma overexpressed
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPB
|
natriuretic peptide B
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
|
NTS
|
neurotensin
|
|
NUCLEOLIN
|
nucleolin multifunctional protein
|
|
OPRM1
|
opioid receptor, mu 1
|
|
PARD3
|
par-3 family cell polarity regulator
|
|
PARK7
|
parkinson protein 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX6
|
paired box 6
|
|
PCDH10
|
protocadherin 10
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PELP1
|
proline, glutamate and leucine rich protein 1
|
|
PFN2
|
profilin 2
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLK1
|
polo-like kinase 1
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
PON1
|
paraoxonase 1
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PRKCI
|
protein kinase C, iota
|
|
PROCR
|
protein C receptor, endothelial
|
|
PROM1
|
prominin 1
|
|
PRPH2
|
peripherin 2 (retinal degeneration, slow)
|
|
PSMB5
|
proteasome (prosome, macropain) subunit, beta type, 5
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PVRL4
|
poliovirus receptor-related 4
|
|
RABL6
|
RAB, member RAS oncogene family-like 6
|
|
RARB
|
retinoic acid receptor, beta
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RET
|
ret proto-oncogene
|
|
RHOH
|
ras homolog family member H
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
RPS19
|
ribosomal protein S19
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RPS6KB2
|
ribosomal protein S6 kinase, 70kDa, polypeptide 2
|
|
RSF1
|
remodeling and spacing factor 1
|
|
RUNX3
|
runt-related transcription factor 3
|
|
S100B
|
S100 calcium binding protein B
|
|
S100P
|
S100 calcium binding protein P
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
|
SETD2
|
SET domain containing 2
|
|
SFTPA1
|
surfactant protein A1
|
|
SFTPD
|
surfactant protein D
|
|
SH3PXD2A
|
SH3 and PX domains 2A
|
|
SHFM1
|
split hand/foot malformation (ectrodactyly) type 1
|
|
SIPA1
|
signal-induced proliferation-associated 1
|
|
SIRT1
|
sirtuin 1
|
|
SLC12A6
|
solute carrier family 12 (potassium/chloride transporter), member 6
|
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1
|
|
SLC22A1
|
solute carrier family 22 (organic cation transporter), member 1
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7
|
|
SMAD1
|
SMAD family member 1
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD4
|
SMAD family member 4
|
|
SNAI2
|
snail family zinc finger 2
|
|
SNRPN
|
small nuclear ribonucleoprotein polypeptide N
|
|
SPOP
|
speckle-type POZ protein
|
|
SPP1
|
secreted phosphoprotein 1
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STEAP1
|
six transmembrane epithelial antigen of the prostate 1
|
|
SUMO4
|
small ubiquitin-like modifier 4
|
|
TBX4
|
T-box 4
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TF
|
transferrin
|
|
TFAM
|
transcription factor A, mitochondrial
|
|
TG
|
thyroglobulin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
THBD
|
thrombomodulin
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TLR4
|
toll-like receptor 4
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP53AIP1
|
tumor protein p53 regulated apoptosis inducing protein 1
|
|
TP53BP2
|
tumor protein p53 binding protein 2
|
|
TP63
|
tumor protein p63
|
|
TPO
|
thyroid peroxidase
|
|
TRA2B
|
transformer 2 beta homolog (Drosophila)
|
|
TRIM24
|
tripartite motif containing 24
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TTR
|
transthyretin
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
UBE3A
|
ubiquitin protein ligase E3A
|
|
UCN
|
urocortin
|
|
UCN2
|
urocortin 2
|
|
ULK1
|
unc-51 like autophagy activating kinase 1
|
|
USP14
|
ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase)
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VTCN1
|
V-set domain containing T cell activation inhibitor 1
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
WT1
|
Wilms tumor 1
|
|
XBP1
|
X-box binding protein 1
|
|
XDH
|
xanthine dehydrogenase
|
|
YWHAG
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZNF148
|
zinc finger protein 148
|
|
ZNF582
|
zinc finger protein 582
|
|
ZNF703
|
zinc finger protein 703
|
